- Home
- KAI vs PCVX Comparison
KAI vs PCVX Comparison
Compare KAI & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAI
- PCVX
- Stock Information
- Founded
- KAI 1991
- PCVX 2013
- Country
- KAI United States
- PCVX United States
- Employees
- KAI N/A
- PCVX N/A
- Industry
- KAI Industrial Machinery/Components
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- KAI Industrials
- PCVX Health Care
- Exchange
- KAI Nasdaq
- PCVX Nasdaq
- Market Cap
- KAI 3.6B
- PCVX 4.0B
- IPO Year
- KAI N/A
- PCVX 2020
- Fundamental
- Price
- KAI $303.54
- PCVX $42.66
- Analyst Decision
- KAI Buy
- PCVX Strong Buy
- Analyst Count
- KAI 2
- PCVX 8
- Target Price
- KAI $340.00
- PCVX $114.17
- AVG Volume (30 Days)
- KAI 125.3K
- PCVX 2.0M
- Earning Date
- KAI 10-28-2025
- PCVX 11-04-2025
- Dividend Yield
- KAI 0.45%
- PCVX N/A
- EPS Growth
- KAI N/A
- PCVX N/A
- EPS
- KAI 8.98
- PCVX N/A
- Revenue
- KAI $1,024,121,000.00
- PCVX N/A
- Revenue This Year
- KAI N/A
- PCVX N/A
- Revenue Next Year
- KAI $5.10
- PCVX N/A
- P/E Ratio
- KAI $33.80
- PCVX N/A
- Revenue Growth
- KAI 1.74
- PCVX N/A
- 52 Week Low
- KAI $281.30
- PCVX $27.66
- 52 Week High
- KAI $429.95
- PCVX $118.62
- Technical
- Relative Strength Index (RSI)
- KAI 43.04
- PCVX 79.03
- Support Level
- KAI $293.00
- PCVX $31.89
- Resistance Level
- KAI $302.08
- PCVX $33.93
- Average True Range (ATR)
- KAI 7.31
- PCVX 1.80
- MACD
- KAI 0.02
- PCVX 1.05
- Stochastic Oscillator
- KAI 48.66
- PCVX 96.26
About KAI Kadant Inc
Kadant Inc. supplies process and engineering equipment for papermaking, recycling, lumber manufacturing, and related industries. The company's three reportable segments are the Flow Control segment which consists of the fluid-handling and doctoring, cleaning, & filtration product lines; the Industrial Processing segment which consists of the wood processing and stock-preparation product lines; and Material handling systems, which provides conveyor-belt equipment for industries such as mining, food processing, and packaging. The company has a geographic presence in the U.S., China, Asia, Germany, Canada, and Others.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.